NEJM Interview: Stacie Dusetzina on a new program that will allow Medicare Part D enrollees to obtain GLP-1 medications for use for weight loss. episode artwork

EPISODE · Jun 24, 2026 · 13 MIN

NEJM Interview: Stacie Dusetzina on a new program that will allow Medicare Part D enrollees to obtain GLP-1 medications for use for weight loss.

from NEJM Interviews

Stacie Dusetzina is a professor of health policy and of cancer research at the Vanderbilt University School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.B. Dusetzina. Access to GLP-1s for Medicare Beneficiaries — A Bridge to Nowhere? N Engl J Med 2026;394:2385-2387.

Episode metadata supplied by the publisher feed · Published Jun 24, 2026

Embed this episode

NOW PLAYING

NEJM Interview: Stacie Dusetzina on a new program that will allow Medicare Part D enrollees to obtain GLP-1 medications for use for weight loss.

0:00 13:06

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of NEJM Interviews?

This episode is 13 minutes long.

When was this NEJM Interviews episode published?

This episode was published on June 24, 2026.

Can I download this NEJM Interviews episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!